{"transactions":[{"id":736154,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":37683,"kind":"person","name":"Lukatch Heath","position":1,"cik":"0001596385","reported_name":"Lukatch Heath","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-16T20:15:18.000Z","date":"2026-06-15","kind":"grant","planned":false,"acquired":true,"shares":11389,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares of Common Stock subject to the option will vest monthly and fully vest on the earlier of June 15, 2027 or the day prior to the next annual meeting of stockholders, subject to acceleration, and subject to the Reporting Person's continuous service through such date."}],"balance_after":11389,"derivative":{"exercise_price":49.56,"expiration_date":"2036-06-15","underlying":"Common Stock","underlying_shares":11389},"source":{"system":"sec-edgar","filing":"0001596385-26-000002","document":"wk-form4_1781640912.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000159638526000002/wk-form4_1781640912.xml","form_type":"4"}},{"id":736153,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":37683,"kind":"person","name":"Lukatch Heath","position":1,"cik":"0001596385","reported_name":"Lukatch Heath","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-16T20:15:18.000Z","date":"2026-06-15","kind":"grant","planned":false,"acquired":true,"shares":2265,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of Common Stock underlying restricted stock units (\"RSUs\"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. The RSUs will fully vest on the earlier of June 15, 2027 or the day prior to the next annual meeting of stockholders, subject to acceleration, and subject to the Reporting Person's continuous service through such date."}],"balance_after":19481,"source":{"system":"sec-edgar","filing":"0001596385-26-000002","document":"wk-form4_1781640912.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000159638526000002/wk-form4_1781640912.xml","form_type":"4"}},{"id":1109756,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":37683,"kind":"person","name":"Lukatch Heath","position":1,"cik":"0001596385","reported_name":"Lukatch Heath","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-16T22:09:25.000Z","date":"2025-06-12","kind":"grant","planned":false,"acquired":true,"shares":15372,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares of Common Stock subject to the option will vest monthly and fully vest on the earlier of June 12, 2026 or the day prior to the next annual meeting of stockholders, subject to acceleration, and subject to the Reporting Person's continuous service through\nsuch date."}],"balance_after":15372,"derivative":{"exercise_price":34.46,"expiration_date":"2035-06-12","underlying":"Common Stock","underlying_shares":15372},"source":{"system":"sec-edgar","filing":"0001596385-25-000004","document":"wk-form4_1750111759.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000159638525000004/wk-form4_1750111759.xml","form_type":"4"}},{"id":1109755,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":37683,"kind":"person","name":"Lukatch Heath","position":1,"cik":"0001596385","reported_name":"Lukatch Heath","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-16T22:09:25.000Z","date":"2025-06-12","kind":"grant","planned":false,"acquired":true,"shares":3041,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of Common Stock underlying restricted stock units (\"RSUs\"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. The RSUs will fully vest on the earlier of June 12, 2026 or the day prior to the next annual meeting of stockholders, subject to acceleration, and subject to the Reporting Person's continuous service through such date."}],"balance_after":17216,"source":{"system":"sec-edgar","filing":"0001596385-25-000004","document":"wk-form4_1750111759.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000159638525000004/wk-form4_1750111759.xml","form_type":"4"}},{"id":1174018,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":37683,"kind":"person","name":"Lukatch Heath","position":1,"cik":"0001596385","reported_name":"Lukatch Heath","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-04-10T12:06:33.000Z","date":"2025-04-08","kind":"exercise","planned":false,"acquired":false,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Fully vested and exercisable."}],"balance_after":14000,"derivative":{"exercise_price":21.49,"expiration_date":"2031-06-01","underlying":"Common Stock","underlying_shares":1000},"source":{"system":"sec-edgar","filing":"0001649094-25-000051","document":"wk-form4_1744286786.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909425000051/wk-form4_1744286786.xml","form_type":"4"}},{"id":1174017,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":37683,"kind":"person","name":"Lukatch Heath","position":1,"cik":"0001596385","reported_name":"Lukatch Heath","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-04-10T12:06:33.000Z","date":"2025-04-08","kind":"exercise","planned":false,"acquired":false,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":16,"expiration_date":"2030-06-10","underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001649094-25-000051","document":"wk-form4_1744286786.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909425000051/wk-form4_1744286786.xml","form_type":"4"}},{"id":1174016,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":37683,"kind":"person","name":"Lukatch Heath","position":1,"cik":"0001596385","reported_name":"Lukatch Heath","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-04-10T12:06:33.000Z","date":"2025-04-08","kind":"exercise","planned":false,"acquired":true,"shares":1000,"price":21.49,"value":21490.0,"ownership":{"direct":true},"balance_after":14175,"source":{"system":"sec-edgar","filing":"0001649094-25-000051","document":"wk-form4_1744286786.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909425000051/wk-form4_1744286786.xml","form_type":"4"}},{"id":1174015,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":37683,"kind":"person","name":"Lukatch Heath","position":1,"cik":"0001596385","reported_name":"Lukatch Heath","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-04-10T12:06:33.000Z","date":"2025-04-08","kind":"exercise","planned":false,"acquired":true,"shares":6000,"price":16,"value":96000.0,"ownership":{"direct":true},"balance_after":13175,"source":{"system":"sec-edgar","filing":"0001649094-25-000051","document":"wk-form4_1744286786.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909425000051/wk-form4_1744286786.xml","form_type":"4"}},{"id":1484897,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":37683,"kind":"person","name":"Lukatch Heath","position":1,"cik":"0001596385","reported_name":"Lukatch Heath","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-10T20:09:52.000Z","date":"2024-06-06","kind":"grant","planned":false,"acquired":true,"shares":7250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares of Common Stock subject to the option will vest monthly and fully vest on the earlier of June 6, 2025 or the day prior to the next annual meeting of stockholders, subject to acceleration, and subject to the Reporting Person's continuous service through such date."}],"balance_after":7250,"derivative":{"exercise_price":72.51,"expiration_date":"2034-06-05","underlying":"Common Stock","underlying_shares":7250},"source":{"system":"sec-edgar","filing":"0001649094-24-000012","document":"wk-form4_1718050182.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000012/wk-form4_1718050182.xml","form_type":"4"}},{"id":1484896,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":37683,"kind":"person","name":"Lukatch Heath","position":1,"cik":"0001596385","reported_name":"Lukatch Heath","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-10T20:09:52.000Z","date":"2024-06-06","kind":"grant","planned":false,"acquired":true,"shares":1550,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of Common Stock underlying restricted stock units (\"RSUs\"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. The RSUs will fully vest on the earlier of June 6, 2025 or the day prior to the next annual meeting of stockholders, subject to acceleration, and subject to the Reporting Person's continuous service through such date."}],"balance_after":7175,"source":{"system":"sec-edgar","filing":"0001649094-24-000012","document":"wk-form4_1718050182.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000012/wk-form4_1718050182.xml","form_type":"4"}},{"id":1661698,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":37683,"kind":"person","name":"Lukatch Heath","position":1,"cik":"0001596385","reported_name":"Lukatch Heath","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-02-02T21:40:28.000Z","date":"2024-01-31","kind":"exercise","planned":true,"acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully vested and exercisable."}],"balance_after":6000,"derivative":{"exercise_price":16,"expiration_date":"2030-06-10","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001415889-24-002320","document":"form4-02022024_090210.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000141588924002320/form4-02022024_090210.xml","form_type":"4"}},{"id":1661697,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":37683,"kind":"person","name":"Lukatch Heath","position":1,"cik":"0001596385","reported_name":"Lukatch Heath","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-02-02T21:40:28.000Z","date":"2024-01-31","kind":"sale","planned":true,"acquired":false,"shares":5000,"price":71.5,"value":357500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 11, 2023."}],"balance_after":5625,"source":{"system":"sec-edgar","filing":"0001415889-24-002320","document":"form4-02022024_090210.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000141588924002320/form4-02022024_090210.xml","form_type":"4"}},{"id":1661696,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":37683,"kind":"person","name":"Lukatch Heath","position":1,"cik":"0001596385","reported_name":"Lukatch Heath","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-02-02T21:40:28.000Z","date":"2024-01-31","kind":"exercise","planned":true,"acquired":true,"shares":5000,"price":16,"value":80000.0,"ownership":{"direct":true},"balance_after":10625,"source":{"system":"sec-edgar","filing":"0001415889-24-002320","document":"form4-02022024_090210.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000141588924002320/form4-02022024_090210.xml","form_type":"4"}},{"id":1665171,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":37683,"kind":"person","name":"Lukatch Heath","position":1,"cik":"0001596385","reported_name":"Lukatch Heath","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-01-31T21:12:41.000Z","date":"2024-01-29","kind":"exercise","planned":true,"acquired":false,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully vested and exercisable."}],"balance_after":11000,"derivative":{"exercise_price":16,"expiration_date":"2030-06-10","underlying":"Common Stock","underlying_shares":4000},"source":{"system":"sec-edgar","filing":"0001415889-24-002058","document":"form4-01312024_090128.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000141588924002058/form4-01312024_090128.xml","form_type":"4"}},{"id":1665170,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":37683,"kind":"person","name":"Lukatch Heath","position":1,"cik":"0001596385","reported_name":"Lukatch Heath","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-01-31T21:12:41.000Z","date":"2024-01-29","kind":"sale","planned":true,"acquired":false,"shares":4000,"price":67.5,"value":270000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 11, 2023."}],"balance_after":5625,"source":{"system":"sec-edgar","filing":"0001415889-24-002058","document":"form4-01312024_090128.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000141588924002058/form4-01312024_090128.xml","form_type":"4"}},{"id":1665169,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":37683,"kind":"person","name":"Lukatch Heath","position":1,"cik":"0001596385","reported_name":"Lukatch Heath","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-01-31T21:12:41.000Z","date":"2024-01-29","kind":"exercise","planned":true,"acquired":true,"shares":4000,"price":16,"value":64000.0,"ownership":{"direct":true},"balance_after":9625,"source":{"system":"sec-edgar","filing":"0001415889-24-002058","document":"form4-01312024_090128.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000141588924002058/form4-01312024_090128.xml","form_type":"4"}},{"id":1687782,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":37683,"kind":"person","name":"Lukatch Heath","position":1,"cik":"0001596385","reported_name":"Lukatch Heath","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-01-04T21:26:50.000Z","date":"2024-01-02","kind":"exercise","planned":true,"acquired":false,"shares":13000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Fully vested and exercisable."}],"balance_after":15000,"derivative":{"exercise_price":16,"expiration_date":"2030-06-10","underlying":"Common Stock","underlying_shares":13000},"source":{"system":"sec-edgar","filing":"0001209191-24-000783","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000120919124000783/doc4.xml","form_type":"4"}},{"id":1687781,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":37683,"kind":"person","name":"Lukatch Heath","position":1,"cik":"0001596385","reported_name":"Lukatch Heath","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-01-04T21:26:50.000Z","date":"2024-01-02","kind":"sale","planned":true,"acquired":false,"shares":291,"price":65.192,"value":18970.872,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 11, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $65.12 to $65.28. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":5625,"source":{"system":"sec-edgar","filing":"0001209191-24-000783","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000120919124000783/doc4.xml","form_type":"4"}},{"id":1687780,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":37683,"kind":"person","name":"Lukatch Heath","position":1,"cik":"0001596385","reported_name":"Lukatch Heath","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-01-04T21:26:50.000Z","date":"2024-01-02","kind":"sale","planned":true,"acquired":false,"shares":4164,"price":64.28,"value":267661.92,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 11, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $64.015 to $64.99. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":5916,"source":{"system":"sec-edgar","filing":"0001209191-24-000783","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000120919124000783/doc4.xml","form_type":"4"}},{"id":1687779,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":37683,"kind":"person","name":"Lukatch Heath","position":1,"cik":"0001596385","reported_name":"Lukatch Heath","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-01-04T21:26:50.000Z","date":"2024-01-02","kind":"sale","planned":true,"acquired":false,"shares":7444,"price":63.552,"value":473081.088,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 11, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $63.01 to $64.00. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":10080,"source":{"system":"sec-edgar","filing":"0001209191-24-000783","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000120919124000783/doc4.xml","form_type":"4"}},{"id":1687778,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":37683,"kind":"person","name":"Lukatch Heath","position":1,"cik":"0001596385","reported_name":"Lukatch Heath","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-01-04T21:26:50.000Z","date":"2024-01-02","kind":"sale","planned":true,"acquired":false,"shares":1101,"price":62.853,"value":69201.153,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 11, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $62.01 to $62.96. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":17524,"source":{"system":"sec-edgar","filing":"0001209191-24-000783","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000120919124000783/doc4.xml","form_type":"4"}},{"id":1687777,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":37683,"kind":"person","name":"Lukatch Heath","position":1,"cik":"0001596385","reported_name":"Lukatch Heath","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-01-04T21:26:50.000Z","date":"2024-01-02","kind":"exercise","planned":true,"acquired":true,"shares":13000,"price":16,"value":208000.0,"ownership":{"direct":true},"balance_after":18625,"source":{"system":"sec-edgar","filing":"0001209191-24-000783","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000120919124000783/doc4.xml","form_type":"4"}},{"id":1854303,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":37683,"kind":"person","name":"Lukatch Heath","position":1,"cik":"0001596385","reported_name":"Lukatch Heath","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-15T21:55:17.000Z","date":"2023-06-13","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares of Common Stock subject to the option will vest monthly and fully vest on the earlier of June 13, 2024 or the day prior to the next annual meeting of stockholders, subject to acceleration, and subject to the Reporting Person's continuous service through such date."}],"balance_after":15000,"derivative":{"exercise_price":53.08,"expiration_date":"2033-06-12","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-23-037508","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000120919123037508/doc4.xml","form_type":"4"}},{"id":1854302,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":37683,"kind":"person","name":"Lukatch Heath","position":1,"cik":"0001596385","reported_name":"Lukatch Heath","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-15T21:55:17.000Z","date":"2023-06-13","kind":"grant","planned":false,"acquired":true,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of Common Stock underlying restricted stock units (\"RSUs\"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. The RSUs will fully vest on the earlier of June 13, 2024 or the day prior to the next annual meeting of stockholders, subject to acceleration, and subject to the Reporting Person's continuous service through such date."}],"balance_after":5625,"source":{"system":"sec-edgar","filing":"0001209191-23-037508","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000120919123037508/doc4.xml","form_type":"4"}},{"id":1862352,"issuer":{"id":112442,"kind":"organization","name":"Satsuma Pharmaceuticals, Inc.","symbol":"STSA"},"owners":[{"id":37683,"kind":"person","name":"Lukatch Heath","position":1,"cik":"0001596385","reported_name":"Lukatch Heath","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-08T16:31:27.000Z","date":"2023-06-08","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Merger Agreement, each option that was not a vested option to purchase Shares of the Issuer with an exercise price that is less than the Offer Price and was outstanding immediately prior to the Effective Time was terminated and cancelled immediately prior to the Effective Time for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Pursuant to the Merger Agreement, each vested option to purchase shares of common stock, par value $0.0001 per share (the \"Shares\") of the Issuer, with an exercise price that is less than the purchase price of $0.91 per share (the \"Offer Price\"), that is outstanding immediately prior to the date and time at which the Merger became effective (the \"Effective Time\") will terminate and be cancelled immediately prior to the Effective Time and converted into the right to receive (a) one non-transferable contractual contingent value right and (b) a lump sum cash payment equal in amount to (i) the number of vested Shares underlying such vested option as of immediately prior to the Effective Time, multiplied by (ii) the excess, if any, of $0.91 over the exercise price per Share underlying such vested option, less any required withholding taxes."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Pursuant to the Merger Agreement, each vested option to purchase shares of common stock, par value $0.0001 per share (the \"Shares\") of the Issuer, with an exercise price that is less than the purchase price of $0.91 per share (the \"Offer Price\"), that is outstanding immediately prior to the date and time at which the Merger became effective (the \"Effective Time\") will terminate and be cancelled immediately prior to the Effective Time and converted into the right to receive (a) one non-transferable contractual contingent value right and (b) a lump sum cash payment equal in amount to (i) the number of vested Shares underlying such vested option as of immediately prior to the Effective Time, multiplied by (ii) the excess, if any, of $0.91 over the exercise price per Share underlying such vested option, less any required withholding taxes."}],"balance_after":0,"derivative":{"exercise_price":3.46,"underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0000899243-23-014878","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1692830/000089924323014878/doc4.xml","form_type":"4"}},{"id":1862351,"issuer":{"id":112442,"kind":"organization","name":"Satsuma Pharmaceuticals, Inc.","symbol":"STSA"},"owners":[{"id":37683,"kind":"person","name":"Lukatch Heath","position":1,"cik":"0001596385","reported_name":"Lukatch Heath","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-08T16:31:27.000Z","date":"2023-06-08","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Merger Agreement, each option that was not a vested option to purchase Shares of the Issuer with an exercise price that is less than the Offer Price and was outstanding immediately prior to the Effective Time was terminated and cancelled immediately prior to the Effective Time for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Pursuant to the Merger Agreement, each vested option to purchase shares of common stock, par value $0.0001 per share (the \"Shares\") of the Issuer, with an exercise price that is less than the purchase price of $0.91 per share (the \"Offer Price\"), that is outstanding immediately prior to the date and time at which the Merger became effective (the \"Effective Time\") will terminate and be cancelled immediately prior to the Effective Time and converted into the right to receive (a) one non-transferable contractual contingent value right and (b) a lump sum cash payment equal in amount to (i) the number of vested Shares underlying such vested option as of immediately prior to the Effective Time, multiplied by (ii) the excess, if any, of $0.91 over the exercise price per Share underlying such vested option, less any required withholding taxes."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Pursuant to the Merger Agreement, each vested option to purchase shares of common stock, par value $0.0001 per share (the \"Shares\") of the Issuer, with an exercise price that is less than the purchase price of $0.91 per share (the \"Offer Price\"), that is outstanding immediately prior to the date and time at which the Merger became effective (the \"Effective Time\") will terminate and be cancelled immediately prior to the Effective Time and converted into the right to receive (a) one non-transferable contractual contingent value right and (b) a lump sum cash payment equal in amount to (i) the number of vested Shares underlying such vested option as of immediately prior to the Effective Time, multiplied by (ii) the excess, if any, of $0.91 over the exercise price per Share underlying such vested option, less any required withholding taxes."}],"balance_after":0,"derivative":{"exercise_price":4.6,"underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0000899243-23-014878","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1692830/000089924323014878/doc4.xml","form_type":"4"}},{"id":1862350,"issuer":{"id":112442,"kind":"organization","name":"Satsuma Pharmaceuticals, Inc.","symbol":"STSA"},"owners":[{"id":37683,"kind":"person","name":"Lukatch Heath","position":1,"cik":"0001596385","reported_name":"Lukatch Heath","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-08T16:31:27.000Z","date":"2023-06-08","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Merger Agreement, each option that was not a vested option to purchase Shares of the Issuer with an exercise price that is less than the Offer Price and was outstanding immediately prior to the Effective Time was terminated and cancelled immediately prior to the Effective Time for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Pursuant to the Merger Agreement, each vested option to purchase shares of common stock, par value $0.0001 per share (the \"Shares\") of the Issuer, with an exercise price that is less than the purchase price of $0.91 per share (the \"Offer Price\"), that is outstanding immediately prior to the date and time at which the Merger became effective (the \"Effective Time\") will terminate and be cancelled immediately prior to the Effective Time and converted into the right to receive (a) one non-transferable contractual contingent value right and (b) a lump sum cash payment equal in amount to (i) the number of vested Shares underlying such vested option as of immediately prior to the Effective Time, multiplied by (ii) the excess, if any, of $0.91 over the exercise price per Share underlying such vested option, less any required withholding taxes."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Pursuant to the Merger Agreement, each vested option to purchase shares of common stock, par value $0.0001 per share (the \"Shares\") of the Issuer, with an exercise price that is less than the purchase price of $0.91 per share (the \"Offer Price\"), that is outstanding immediately prior to the date and time at which the Merger became effective (the \"Effective Time\") will terminate and be cancelled immediately prior to the Effective Time and converted into the right to receive (a) one non-transferable contractual contingent value right and (b) a lump sum cash payment equal in amount to (i) the number of vested Shares underlying such vested option as of immediately prior to the Effective Time, multiplied by (ii) the excess, if any, of $0.91 over the exercise price per Share underlying such vested option, less any required withholding taxes."}],"balance_after":0,"derivative":{"exercise_price":27.97,"underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0000899243-23-014878","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1692830/000089924323014878/doc4.xml","form_type":"4"}},{"id":2055639,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":37683,"kind":"person","name":"Lukatch Heath","position":1,"cik":"0001596385","reported_name":"Lukatch Heath","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-01-12T21:33:18.000Z","date":"2023-01-10","kind":"exercise","acquired":false,"shares":315,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"1/3 of the shares subject to the option vest on June 11, 2021, and 1/36 of the shares vest monthly thereafter."}],"balance_after":28000,"derivative":{"exercise_price":16,"expiration_date":"2030-06-10","underlying":"Common Stock","underlying_shares":315},"source":{"system":"sec-edgar","filing":"0001209191-23-003152","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000120919123003152/doc4.xml","form_type":"4"}},{"id":2055638,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":37683,"kind":"person","name":"Lukatch Heath","position":1,"cik":"0001596385","reported_name":"Lukatch Heath","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-01-12T21:33:18.000Z","date":"2023-01-10","kind":"sale","acquired":false,"shares":82,"price":46.3274,"value":3798.8468,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $46.29 to $46.385. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":3125,"source":{"system":"sec-edgar","filing":"0001209191-23-003152","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000120919123003152/doc4.xml","form_type":"4"}},{"id":2055637,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":37683,"kind":"person","name":"Lukatch Heath","position":1,"cik":"0001596385","reported_name":"Lukatch Heath","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-01-12T21:33:18.000Z","date":"2023-01-10","kind":"sale","acquired":false,"shares":233,"price":46.0413,"value":10727.6229,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $45.27 to $46.23. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":3207,"source":{"system":"sec-edgar","filing":"0001209191-23-003152","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000120919123003152/doc4.xml","form_type":"4"}},{"id":2055636,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":37683,"kind":"person","name":"Lukatch Heath","position":1,"cik":"0001596385","reported_name":"Lukatch Heath","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-01-12T21:33:18.000Z","date":"2023-01-10","kind":"exercise","acquired":true,"shares":315,"price":16,"value":5040.0,"ownership":{"direct":true},"balance_after":3440,"source":{"system":"sec-edgar","filing":"0001209191-23-003152","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000120919123003152/doc4.xml","form_type":"4"}},{"id":2086460,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":37683,"kind":"person","name":"Lukatch Heath","position":1,"cik":"0001596385","reported_name":"Lukatch Heath","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-12-14T22:03:41.000Z","date":"2022-12-12","kind":"exercise","acquired":false,"shares":335,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/3 of the shares subject to the option vest on June 11, 2021, and 1/36 of the shares vest monthly thereafter."}],"balance_after":28315,"derivative":{"exercise_price":16,"expiration_date":"2030-06-10","underlying":"Common Stock","underlying_shares":335},"source":{"system":"sec-edgar","filing":"0001209191-22-061256","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000120919122061256/doc4.xml","form_type":"4"}},{"id":2086459,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":37683,"kind":"person","name":"Lukatch Heath","position":1,"cik":"0001596385","reported_name":"Lukatch Heath","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-12-14T22:03:41.000Z","date":"2022-12-12","kind":"sale","acquired":false,"shares":319,"price":44.0103,"value":14039.2857,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $43.745 to $44.43. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":3125,"source":{"system":"sec-edgar","filing":"0001209191-22-061256","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000120919122061256/doc4.xml","form_type":"4"}},{"id":2086458,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":37683,"kind":"person","name":"Lukatch Heath","position":1,"cik":"0001596385","reported_name":"Lukatch Heath","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-12-14T22:03:41.000Z","date":"2022-12-12","kind":"sale","acquired":false,"shares":16,"price":42.365,"value":677.84,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":3444,"source":{"system":"sec-edgar","filing":"0001209191-22-061256","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000120919122061256/doc4.xml","form_type":"4"}},{"id":2086457,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":37683,"kind":"person","name":"Lukatch Heath","position":1,"cik":"0001596385","reported_name":"Lukatch Heath","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-12-14T22:03:41.000Z","date":"2022-12-12","kind":"exercise","acquired":true,"shares":335,"price":16,"value":5360.0,"ownership":{"direct":true},"balance_after":3460,"source":{"system":"sec-edgar","filing":"0001209191-22-061256","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000120919122061256/doc4.xml","form_type":"4"}},{"id":2116092,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":37683,"kind":"person","name":"Lukatch Heath","position":1,"cik":"0001596385","reported_name":"Lukatch Heath","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-11-15T21:59:16.000Z","date":"2022-11-10","kind":"exercise","acquired":false,"shares":4335,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/3 of the shares subject to the option vest on June 11, 2021, and 1/36 of the shares vest monthly thereafter."}],"balance_after":28650,"derivative":{"exercise_price":16,"expiration_date":"2030-06-10","underlying":"Common Stock","underlying_shares":4335},"source":{"system":"sec-edgar","filing":"0001209191-22-057030","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000120919122057030/doc4.xml","form_type":"4"}},{"id":2116091,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":37683,"kind":"person","name":"Lukatch Heath","position":1,"cik":"0001596385","reported_name":"Lukatch Heath","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-11-15T21:59:16.000Z","date":"2022-11-10","kind":"sale","acquired":false,"shares":4000,"price":46.25,"value":185000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":3125,"source":{"system":"sec-edgar","filing":"0001209191-22-057030","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000120919122057030/doc4.xml","form_type":"4"}},{"id":2116090,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":37683,"kind":"person","name":"Lukatch Heath","position":1,"cik":"0001596385","reported_name":"Lukatch Heath","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-11-15T21:59:16.000Z","date":"2022-11-10","kind":"sale","acquired":false,"shares":335,"price":44.742,"value":14988.57,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $44.51 to $45.28. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":7125,"source":{"system":"sec-edgar","filing":"0001209191-22-057030","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000120919122057030/doc4.xml","form_type":"4"}},{"id":2116089,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":37683,"kind":"person","name":"Lukatch Heath","position":1,"cik":"0001596385","reported_name":"Lukatch Heath","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-11-15T21:59:16.000Z","date":"2022-11-10","kind":"exercise","acquired":true,"shares":4335,"price":16,"value":69360.0,"ownership":{"direct":true},"balance_after":7460,"source":{"system":"sec-edgar","filing":"0001209191-22-057030","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000120919122057030/doc4.xml","form_type":"4"}},{"id":2131620,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":37683,"kind":"person","name":"Lukatch Heath","position":1,"cik":"0001596385","reported_name":"Lukatch Heath","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-10-26T21:54:01.000Z","date":"2022-10-26","kind":"disposition_to_issuer","acquired":false,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/3 of the shares subject to the option vest on June 11, 2021, and 1/36 of the shares vest monthly thereafter."}],"balance_after":32985,"derivative":{"exercise_price":16,"expiration_date":"2030-06-10","underlying":"Common Stock","underlying_shares":4000},"source":{"system":"sec-edgar","filing":"0001209191-22-054664","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000120919122054664/doc4.xml","form_type":"4"}},{"id":2131619,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":37683,"kind":"person","name":"Lukatch Heath","position":1,"cik":"0001596385","reported_name":"Lukatch Heath","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-10-26T21:54:01.000Z","date":"2022-10-24","kind":"disposition_to_issuer","acquired":false,"shares":3015,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/3 of the shares subject to the option vest on June 11, 2021, and 1/36 of the shares vest monthly thereafter."}],"balance_after":36985,"derivative":{"exercise_price":16,"expiration_date":"2030-06-10","underlying":"Common Stock","underlying_shares":3015},"source":{"system":"sec-edgar","filing":"0001209191-22-054664","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000120919122054664/doc4.xml","form_type":"4"}},{"id":2131618,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":37683,"kind":"person","name":"Lukatch Heath","position":1,"cik":"0001596385","reported_name":"Lukatch Heath","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-10-26T21:54:01.000Z","date":"2022-10-26","kind":"sale","acquired":false,"shares":4000,"price":38.25,"value":153000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":3125,"source":{"system":"sec-edgar","filing":"0001209191-22-054664","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000120919122054664/doc4.xml","form_type":"4"}},{"id":2131617,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":37683,"kind":"person","name":"Lukatch Heath","position":1,"cik":"0001596385","reported_name":"Lukatch Heath","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-10-26T21:54:01.000Z","date":"2022-10-26","kind":"exercise","acquired":true,"shares":4000,"price":16,"value":64000.0,"ownership":{"direct":true},"balance_after":7125,"source":{"system":"sec-edgar","filing":"0001209191-22-054664","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000120919122054664/doc4.xml","form_type":"4"}},{"id":2131616,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":37683,"kind":"person","name":"Lukatch Heath","position":1,"cik":"0001596385","reported_name":"Lukatch Heath","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-10-26T21:54:01.000Z","date":"2022-10-24","kind":"sale","acquired":false,"shares":3015,"price":35.11,"value":105856.65,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":3125,"source":{"system":"sec-edgar","filing":"0001209191-22-054664","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000120919122054664/doc4.xml","form_type":"4"}},{"id":2131615,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":37683,"kind":"person","name":"Lukatch Heath","position":1,"cik":"0001596385","reported_name":"Lukatch Heath","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-10-26T21:54:01.000Z","date":"2022-10-24","kind":"exercise","acquired":true,"shares":3015,"price":16,"value":48240.0,"ownership":{"direct":true},"balance_after":6140,"source":{"system":"sec-edgar","filing":"0001209191-22-054664","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000120919122054664/doc4.xml","form_type":"4"}},{"id":2240211,"issuer":{"id":112442,"kind":"organization","name":"Satsuma Pharmaceuticals, Inc.","symbol":"STSA"},"owners":[{"id":37683,"kind":"person","name":"Lukatch Heath","position":1,"cik":"0001596385","reported_name":"Lukatch Heath","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-07T17:38:09.000Z","date":"2022-06-03","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest in full and become exercisable on the day immediately preceding the 2023 Annual Meeting."}],"balance_after":30000,"derivative":{"exercise_price":3.46,"expiration_date":"2032-06-02","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001567619-22-012476","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1692830/000156761922012476/doc1.xml","form_type":"4"}},{"id":2244709,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":37683,"kind":"person","name":"Lukatch Heath","position":1,"cik":"0001596385","reported_name":"Lukatch Heath","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-03T20:31:12.000Z","date":"2022-06-01","kind":"grant","acquired":true,"shares":18750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares of Common Stock subject to the option will vest monthly and fully vest on the earlier of June 1, 2023 or the day prior to the next annual meeting of stockholders, subject to acceleration, and subject to the Reporting Person's continuous service through such date."}],"balance_after":18750,"derivative":{"exercise_price":22.7,"expiration_date":"2032-05-31","underlying":"Common Stock","underlying_shares":18750},"source":{"system":"sec-edgar","filing":"0001209191-22-034061","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000120919122034061/doc4.xml","form_type":"4"}},{"id":2244708,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":37683,"kind":"person","name":"Lukatch Heath","position":1,"cik":"0001596385","reported_name":"Lukatch Heath","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-03T20:31:12.000Z","date":"2022-06-01","kind":"grant","acquired":true,"shares":3125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of Common Stock underlying restricted stock units (\"RSUs\"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. The RSUs will fully vest on the earlier of June 1, 2023 or the day prior to the next annual meeting of stockholders, subject to acceleration, and subject to the Reporting Person's continuous service through such date."}],"balance_after":3125,"source":{"system":"sec-edgar","filing":"0001209191-22-034061","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000120919122034061/doc4.xml","form_type":"4"}},{"id":2502643,"issuer":{"id":16545,"kind":"organization","name":"Flexion Therapeutics Inc","symbol":"FLXN"},"owners":[{"id":37683,"kind":"person","name":"Lukatch Heath","position":1,"cik":"0001596385","reported_name":"Lukatch Heath","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2021-11-19T10:16:24.000Z","date":"2021-11-19","kind":"disposition_to_issuer","acquired":false,"shares":7000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"At the effective time of the Merger, each outstanding option with an exercise price equal to, or greater than, $9.12 was cancelled without any consideration payable (whether in the form of cash or any potential CVR Payments) in respect of such cancelled option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"At the effective time of the Merger, each outstanding option with an exercise price equal to, or greater than, $9.12 was cancelled without any consideration payable (whether in the form of cash or any potential CVR Payments) in respect of such cancelled option."}],"balance_after":0,"derivative":{"exercise_price":9.22,"expiration_date":"2031-06-23","underlying":"Common Stock","underlying_shares":7000},"source":{"system":"sec-edgar","filing":"0001209191-21-065719","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1419600/000120919121065719/doc4.xml","form_type":"4"}},{"id":2502642,"issuer":{"id":16545,"kind":"organization","name":"Flexion Therapeutics Inc","symbol":"FLXN"},"owners":[{"id":37683,"kind":"person","name":"Lukatch Heath","position":1,"cik":"0001596385","reported_name":"Lukatch Heath","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2021-11-19T10:16:24.000Z","date":"2021-11-19","kind":"disposition_to_issuer","acquired":false,"shares":7000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"At the effective time of the Merger, each outstanding option with an exercise price equal to, or greater than, $9.12 was cancelled without any consideration payable (whether in the form of cash or any potential CVR Payments) in respect of such cancelled option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"At the effective time of the Merger, each outstanding option with an exercise price equal to, or greater than, $9.12 was cancelled without any consideration payable (whether in the form of cash or any potential CVR Payments) in respect of such cancelled option."}],"balance_after":0,"derivative":{"exercise_price":11.88,"expiration_date":"2030-06-09","underlying":"Common Stock","underlying_shares":7000},"source":{"system":"sec-edgar","filing":"0001209191-21-065719","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1419600/000120919121065719/doc4.xml","form_type":"4"}},{"id":2502641,"issuer":{"id":16545,"kind":"organization","name":"Flexion Therapeutics Inc","symbol":"FLXN"},"owners":[{"id":37683,"kind":"person","name":"Lukatch Heath","position":1,"cik":"0001596385","reported_name":"Lukatch Heath","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2021-11-19T10:16:24.000Z","date":"2021-11-19","kind":"disposition_to_issuer","acquired":false,"shares":12500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"At the effective time of the Merger, each outstanding option with an exercise price equal to, or greater than, $9.12 was cancelled without any consideration payable (whether in the form of cash or any potential CVR Payments) in respect of such cancelled option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"At the effective time of the Merger, each outstanding option with an exercise price equal to, or greater than, $9.12 was cancelled without any consideration payable (whether in the form of cash or any potential CVR Payments) in respect of such cancelled option."}],"balance_after":0,"derivative":{"exercise_price":20.16,"expiration_date":"2027-06-21","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001209191-21-065719","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1419600/000120919121065719/doc4.xml","form_type":"4"}},{"id":2502640,"issuer":{"id":16545,"kind":"organization","name":"Flexion Therapeutics Inc","symbol":"FLXN"},"owners":[{"id":37683,"kind":"person","name":"Lukatch Heath","position":1,"cik":"0001596385","reported_name":"Lukatch Heath","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2021-11-19T10:16:24.000Z","date":"2021-11-19","kind":"disposition_to_issuer","acquired":false,"shares":12500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"At the effective time of the Merger, each outstanding option with an exercise price equal to, or greater than, $9.12 was cancelled without any consideration payable (whether in the form of cash or any potential CVR Payments) in respect of such cancelled option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"At the effective time of the Merger, each outstanding option with an exercise price equal to, or greater than, $9.12 was cancelled without any consideration payable (whether in the form of cash or any potential CVR Payments) in respect of such cancelled option."}],"balance_after":0,"derivative":{"exercise_price":13.83,"expiration_date":"2026-06-09","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001209191-21-065719","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1419600/000120919121065719/doc4.xml","form_type":"4"}},{"id":2502639,"issuer":{"id":16545,"kind":"organization","name":"Flexion Therapeutics Inc","symbol":"FLXN"},"owners":[{"id":37683,"kind":"person","name":"Lukatch Heath","position":1,"cik":"0001596385","reported_name":"Lukatch Heath","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2021-11-19T10:16:24.000Z","date":"2021-11-19","kind":"disposition_to_issuer","acquired":false,"shares":9000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"At the effective time of the Merger, each outstanding option with an exercise price equal to, or greater than, $9.12 was cancelled without any consideration payable (whether in the form of cash or any potential CVR Payments) in respect of such cancelled option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"At the effective time of the Merger, each outstanding option with an exercise price equal to, or greater than, $9.12 was cancelled without any consideration payable (whether in the form of cash or any potential CVR Payments) in respect of such cancelled option."}],"balance_after":0,"derivative":{"exercise_price":21.85,"expiration_date":"2025-06-16","underlying":"Common Stock","underlying_shares":9000},"source":{"system":"sec-edgar","filing":"0001209191-21-065719","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1419600/000120919121065719/doc4.xml","form_type":"4"}},{"id":2502638,"issuer":{"id":16545,"kind":"organization","name":"Flexion Therapeutics Inc","symbol":"FLXN"},"owners":[{"id":37683,"kind":"person","name":"Lukatch Heath","position":1,"cik":"0001596385","reported_name":"Lukatch Heath","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-11-19T10:16:24.000Z","date":"2021-11-19","kind":"disposition_to_issuer","acquired":false,"shares":9000,"price":8.5,"value":76500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, dated as of October 11, 2021, by and among Flexion Therapeutics, Inc. (\"Issuer\"), Pacira BioSciences, Inc. and Oyster Acquisition Company Inc. (\"Purchaser\") (\"Merger Agreement\"), on November 19, 2021, Purchaser merged with and into Issuer, with Issuer continuing as the surviving corporation (\"Merger\"). At the effective time of the Merger, each share of Issuer's common stock was cancelled in exchange for (i) $8.50 per share in cash (\"Cash Amount\"), plus (ii) one non-transferable contractual contingent value right per share, which represent the right to receive one or more contingent payments of up to $8.00 per share in the aggregate, in cash, upon the achievement of specified milestones on or prior to December 31, 2030 (\"CVR Payments\"). Pursuant to the Merger Agreement, these shares were tendered and disposed of at the offer acceptance time in exchange for the right to receive (i) the Cash Amount, plus (ii) any CVR Payments."},{"field":"shares","element":"transactionShares","label":"F2","text":"At the effective time of the Merger, each outstanding restricted stock unit award (\"RSU\") was accelerated and became fully vested and was cancelled and converted into the right to receive (i) $8.50 per share of Issuer common stock issuable in settlement of such RSU in cash, net of any withholding taxes required to be deducted and withheld by applicable law, plus (ii) any potential CVR Payments."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-21-065719","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419600/000120919121065719/doc4.xml","form_type":"4"}},{"id":2653287,"issuer":{"id":16545,"kind":"organization","name":"Flexion Therapeutics Inc","symbol":"FLXN"},"owners":[{"id":37683,"kind":"person","name":"Lukatch Heath","position":1,"cik":"0001596385","reported_name":"Lukatch Heath","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-28T18:25:55.000Z","date":"2021-06-24","kind":"grant","acquired":true,"shares":7000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests and becomes exercisable in 12 equal monthly installments following the date of grant."}],"balance_after":7000,"derivative":{"exercise_price":9.22,"expiration_date":"2031-06-23","underlying":"Common Stock","underlying_shares":7000},"source":{"system":"sec-edgar","filing":"0001209191-21-043546","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1419600/000120919121043546/doc4.xml","form_type":"4"}},{"id":2653286,"issuer":{"id":16545,"kind":"organization","name":"Flexion Therapeutics Inc","symbol":"FLXN"},"owners":[{"id":37683,"kind":"person","name":"Lukatch Heath","position":1,"cik":"0001596385","reported_name":"Lukatch Heath","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-28T18:25:55.000Z","date":"2021-06-24","kind":"grant","acquired":true,"shares":4500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted stock unit award granted under the Issuer's 2013 Equity Incentive Plan."}],"balance_after":9000,"source":{"system":"sec-edgar","filing":"0001209191-21-043546","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419600/000120919121043546/doc4.xml","form_type":"4"}},{"id":2683268,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":37683,"kind":"person","name":"Lukatch Heath","position":1,"cik":"0001596385","reported_name":"Lukatch Heath","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-03T22:48:54.000Z","date":"2021-06-02","kind":"grant","acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest monthly and fully vest on the earlier of June 2, 2022 or the day prior to the next annual meeting of stockholders, subject to the Reporting Person's continuous service through such date."}],"balance_after":15000,"derivative":{"exercise_price":21.49,"expiration_date":"2031-06-01","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-21-037899","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000120919121037899/doc4.xml","form_type":"4"}},{"id":2716169,"issuer":{"id":2083,"kind":"organization","name":"Inogen Inc","symbol":"INGN"},"owners":[{"id":37683,"kind":"person","name":"Lukatch Heath","position":1,"cik":"0001596385","reported_name":"Lukatch Heath","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-12T23:52:27.000Z","date":"2021-05-10","kind":"grant","acquired":true,"shares":2754,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported shares were acquired pursuant to a restricted stock unit award, which shall vest on the earlier of (i) the one-year anniversary of the date of grant, or (ii) the day prior to the date of the Annual Meeting of the Issuer's stockholders next following the date of grant, in each case, subject to the reporting person continuing to be a service provider through the applicable vesting date."}],"balance_after":12775,"source":{"system":"sec-edgar","filing":"0001209191-21-032227","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1294133/000120919121032227/doc4.xml","form_type":"4"}},{"id":2955264,"issuer":{"id":112442,"kind":"organization","name":"Satsuma Pharmaceuticals, Inc.","symbol":"STSA"},"owners":[{"id":37683,"kind":"person","name":"Lukatch Heath","position":1,"cik":"0001596385","reported_name":"Lukatch Heath","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-12-07T18:04:56.000Z","date":"2020-12-03","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest in full and become exercisable on the day immediately preceding the 2022 Annual Meeting."}],"balance_after":20000,"derivative":{"exercise_price":4.6,"expiration_date":"2030-12-03","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001567619-20-020721","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1692830/000156761920020721/doc1.xml","form_type":"4"}},{"id":3096677,"issuer":{"id":112442,"kind":"organization","name":"Satsuma Pharmaceuticals, Inc.","symbol":"STSA"},"owners":[{"id":37683,"kind":"person","name":"Lukatch Heath","position":1,"cik":"0001596385","reported_name":"Lukatch Heath","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-30T16:11:58.000Z","date":"2020-06-29","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The underlying shares subject to the option vest and become exercisable in successive, equal monthly installments over two years measured from June 12, 2020, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."}],"balance_after":20000,"derivative":{"exercise_price":27.97,"expiration_date":"2030-06-12","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001567619-20-012688","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1692830/000156761920012688/doc1.xml","form_type":"4"}},{"id":3109165,"issuer":{"id":112442,"kind":"organization","name":"Satsuma Pharmaceuticals, Inc.","symbol":"STSA"},"owners":[{"id":37683,"kind":"person","name":"Lukatch Heath","position":1,"cik":"0001596385","reported_name":"Lukatch Heath","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-16T19:24:48.000Z","date":"2020-06-12","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The option was issued pursuant to the Issuer's Non-Employee Director Compensation Program."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option shall vest and become exercisable on the earlier of (i) the day immediately preceding the date of the first Annual Meeting following the date of grant and (ii) the  first anniversary of the date of grant, subject to the Non-Employee Director continuing in service on the Board through the applicable vesting date."}],"balance_after":10000,"derivative":{"exercise_price":26.99,"expiration_date":"2030-06-11","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001567619-20-012250","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1692830/000156761920012250/doc1.xml","form_type":"4"}},{"id":3110573,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":37683,"kind":"person","name":"Lukatch Heath","position":1,"cik":"0001596385","reported_name":"Lukatch Heath","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-06-15T22:17:46.000Z","date":"2020-06-11","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/3 of the shares subject to the option vest on June 11, 2021, and 1/36 of the shares vest monthly thereafter."}],"balance_after":40000,"derivative":{"exercise_price":16,"expiration_date":"2030-06-10","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001209191-20-036739","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000120919120036739/doc4.xml","form_type":"4"}},{"id":3111656,"issuer":{"id":16545,"kind":"organization","name":"Flexion Therapeutics Inc","symbol":"FLXN"},"owners":[{"id":37683,"kind":"person","name":"Lukatch Heath","position":1,"cik":"0001596385","reported_name":"Lukatch Heath","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-12T16:15:51.000Z","date":"2020-06-10","kind":"grant","acquired":true,"shares":7000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests and becomes exercisable in 12 equal monthly installments following the date of grant."}],"balance_after":7000,"derivative":{"exercise_price":11.88,"expiration_date":"2030-06-09","underlying":"Common Stock","underlying_shares":7000},"source":{"system":"sec-edgar","filing":"0001209191-20-036253","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1419600/000120919120036253/doc4.xml","form_type":"4"}},{"id":3111655,"issuer":{"id":16545,"kind":"organization","name":"Flexion Therapeutics Inc","symbol":"FLXN"},"owners":[{"id":37683,"kind":"person","name":"Lukatch Heath","position":1,"cik":"0001596385","reported_name":"Lukatch Heath","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-12T16:15:51.000Z","date":"2020-06-10","kind":"grant","acquired":true,"shares":4500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock unit award granted under the Issuer's 2013 Equity Incentive Plan."}],"balance_after":4500,"source":{"system":"sec-edgar","filing":"0001209191-20-036253","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419600/000120919120036253/doc4.xml","form_type":"4"}},{"id":3152477,"issuer":{"id":2083,"kind":"organization","name":"Inogen Inc","symbol":"INGN"},"owners":[{"id":37683,"kind":"person","name":"Lukatch Heath","position":1,"cik":"0001596385","reported_name":"Lukatch Heath","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-12T22:34:32.000Z","date":"2020-05-11","kind":"grant","acquired":true,"shares":4540,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported shares were acquired pursuant to a restricted stock unit award, which shall vest on the earlier of (i) the one-year anniversary of the date of grant, or (ii) the day prior to the date of the Annual Meeting of the Issuer's stockholders next following the date of grant, in each case, subject to the Reporting Person continuing to be a service provider through the applicable vesting date."}],"balance_after":10021,"source":{"system":"sec-edgar","filing":"0001209191-20-028630","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1294133/000120919120028630/doc4.xml","form_type":"4"}},{"id":3434320,"issuer":{"id":2083,"kind":"organization","name":"Inogen Inc","symbol":"INGN"},"owners":[{"id":37683,"kind":"person","name":"Lukatch Heath","position":1,"cik":"0001596385","reported_name":"Lukatch Heath","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-08-20T00:11:42.000Z","date":"2019-08-15","kind":"purchase","acquired":true,"shares":2000,"price":43.01,"value":86020.0,"ownership":{"direct":true},"balance_after":5481,"source":{"system":"sec-edgar","filing":"0001209191-19-046733","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1294133/000120919119046733/doc4.xml","form_type":"4"}},{"id":3516734,"issuer":{"id":2083,"kind":"organization","name":"Inogen Inc","symbol":"INGN"},"owners":[{"id":37683,"kind":"person","name":"Lukatch Heath","position":1,"cik":"0001596385","reported_name":"Lukatch Heath","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-05-22T01:08:56.000Z","date":"2019-05-09","kind":"grant","acquired":true,"shares":2492,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported shares were acquired pursuant to a restricted stock unit award, which shall vest on the earlier of (i) the one-year anniversary of the date of grant, or (ii) the day prior to the date of the Annual Meeting of the Issuer's stockholders next following the date of grant, in each case, subject to the reporting person continuing to be a service provider through the applicable vesting date."}],"balance_after":3481,"source":{"system":"sec-edgar","filing":"0001209191-19-031889","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1294133/000120919119031889/doc4a.xml","form_type":"4/A","original_submission_date":"2019-05-10"}},{"id":3531343,"issuer":{"id":2083,"kind":"organization","name":"Inogen Inc","symbol":"INGN"},"owners":[{"id":37683,"kind":"person","name":"Lukatch Heath","position":1,"cik":"0001596385","reported_name":"Lukatch Heath","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-05-10T20:50:00.000Z","date":"2019-05-09","kind":"grant","acquired":true,"shares":2474,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported shares were acquired pursuant to a restricted stock unit award, which shall vest on the earlier of (i) the one-year anniversary of the date of grant, or (ii) the day prior to the date of the Annual Meeting of the Issuer's stockholders next following the date of grant, in each case, subject to the reporting person continuing to be a service provider through the applicable vesting date."}],"balance_after":3463,"source":{"system":"sec-edgar","filing":"0001209191-19-028985","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1294133/000120919119028985/doc4.xml","form_type":"4"}},{"id":3770450,"issuer":{"id":2083,"kind":"organization","name":"Inogen Inc","symbol":"INGN"},"owners":[{"id":37683,"kind":"person","name":"Lukatch Heath","position":1,"cik":"0001596385","reported_name":"Lukatch Heath","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-11-08T19:39:50.000Z","date":"2018-11-06","kind":"exercise","acquired":false,"shares":500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Subject to reporting person's continuing to be a Service Provider (as defined in the 2014 Equity Incentive Plan), 1/12th of the total shares subject to the option vested monthly, beginning with the first month anniversary after the vesting commencement date, but vested fully on the date of the 2016 Annual Meeting of the Issuer's stockholders held after the vesting commencement date. The vesting commencement date for this option was October 14, 2015."}],"balance_after":6665,"derivative":{"exercise_price":43.21,"expiration_date":"2022-10-13","underlying":"Common Stock","underlying_shares":500},"source":{"system":"sec-edgar","filing":"0001209191-18-057722","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1294133/000120919118057722/doc4.xml","form_type":"4"}},{"id":3770449,"issuer":{"id":2083,"kind":"organization","name":"Inogen Inc","symbol":"INGN"},"owners":[{"id":37683,"kind":"person","name":"Lukatch Heath","position":1,"cik":"0001596385","reported_name":"Lukatch Heath","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-11-08T19:39:50.000Z","date":"2018-11-06","kind":"sale","acquired":false,"shares":100,"price":196.82,"value":19682.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 2, 2018."}],"balance_after":989,"source":{"system":"sec-edgar","filing":"0001209191-18-057722","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1294133/000120919118057722/doc4.xml","form_type":"4"}},{"id":3770448,"issuer":{"id":2083,"kind":"organization","name":"Inogen Inc","symbol":"INGN"},"owners":[{"id":37683,"kind":"person","name":"Lukatch Heath","position":1,"cik":"0001596385","reported_name":"Lukatch Heath","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-11-08T19:39:50.000Z","date":"2018-11-06","kind":"sale","acquired":false,"shares":100,"price":195.07,"value":19507.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 2, 2018."}],"balance_after":1089,"source":{"system":"sec-edgar","filing":"0001209191-18-057722","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1294133/000120919118057722/doc4.xml","form_type":"4"}},{"id":3770447,"issuer":{"id":2083,"kind":"organization","name":"Inogen Inc","symbol":"INGN"},"owners":[{"id":37683,"kind":"person","name":"Lukatch Heath","position":1,"cik":"0001596385","reported_name":"Lukatch Heath","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-11-08T19:39:50.000Z","date":"2018-11-06","kind":"sale","acquired":false,"shares":300,"price":192.66,"value":57798.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 2, 2018."}],"balance_after":1189,"source":{"system":"sec-edgar","filing":"0001209191-18-057722","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1294133/000120919118057722/doc4.xml","form_type":"4"}},{"id":3770446,"issuer":{"id":2083,"kind":"organization","name":"Inogen Inc","symbol":"INGN"},"owners":[{"id":37683,"kind":"person","name":"Lukatch Heath","position":1,"cik":"0001596385","reported_name":"Lukatch Heath","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-11-08T19:39:50.000Z","date":"2018-11-06","kind":"exercise","acquired":true,"shares":500,"price":43.21,"value":21605.0,"ownership":{"direct":true},"balance_after":1489,"source":{"system":"sec-edgar","filing":"0001209191-18-057722","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1294133/000120919118057722/doc4.xml","form_type":"4"}},{"id":3794208,"issuer":{"id":2083,"kind":"organization","name":"Inogen Inc","symbol":"INGN"},"owners":[{"id":37683,"kind":"person","name":"Lukatch Heath","position":1,"cik":"0001596385","reported_name":"Lukatch Heath","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-10-09T21:13:24.000Z","date":"2018-10-05","kind":"exercise","acquired":false,"shares":500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Subject to reporting person's continuing to be a Service Provider (as defined in the 2014 Equity Incentive Plan), 1/12th of the total shares subject to the option vested monthly, beginning with the first month anniversary after the vesting commencement date, but vested fully on the date of the 2016 Annual Meeting of the Issuer's stockholders held after the vesting commencement date. The vesting commencement date for this option was October 14, 2015."}],"balance_after":7165,"derivative":{"exercise_price":43.21,"expiration_date":"2022-10-13","underlying":"Common Stock","underlying_shares":500},"source":{"system":"sec-edgar","filing":"0001209191-18-054560","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1294133/000120919118054560/doc4.xml","form_type":"4"}},{"id":3794207,"issuer":{"id":2083,"kind":"organization","name":"Inogen Inc","symbol":"INGN"},"owners":[{"id":37683,"kind":"person","name":"Lukatch Heath","position":1,"cik":"0001596385","reported_name":"Lukatch Heath","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-10-09T21:13:24.000Z","date":"2018-10-05","kind":"sale","acquired":false,"shares":10,"price":220.56,"value":2205.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 2, 2018."}],"balance_after":989,"source":{"system":"sec-edgar","filing":"0001209191-18-054560","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1294133/000120919118054560/doc4.xml","form_type":"4"}},{"id":3794206,"issuer":{"id":2083,"kind":"organization","name":"Inogen Inc","symbol":"INGN"},"owners":[{"id":37683,"kind":"person","name":"Lukatch Heath","position":1,"cik":"0001596385","reported_name":"Lukatch Heath","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-10-09T21:13:24.000Z","date":"2018-10-05","kind":"sale","acquired":false,"shares":130,"price":219.1731,"value":28492.503,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 2, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Represents the weighted average share price of an aggregate total of 130 shares sold in the price range of $219.10 to $219.73 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":999,"source":{"system":"sec-edgar","filing":"0001209191-18-054560","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1294133/000120919118054560/doc4.xml","form_type":"4"}},{"id":3794205,"issuer":{"id":2083,"kind":"organization","name":"Inogen Inc","symbol":"INGN"},"owners":[{"id":37683,"kind":"person","name":"Lukatch Heath","position":1,"cik":"0001596385","reported_name":"Lukatch Heath","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-10-09T21:13:24.000Z","date":"2018-10-05","kind":"sale","acquired":false,"shares":260,"price":218.8542,"value":56902.092,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 2, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Represents the weighted average share price of an aggregate total of 260 shares sold in the price range of $218.10 to $219.04 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":1129,"source":{"system":"sec-edgar","filing":"0001209191-18-054560","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1294133/000120919118054560/doc4.xml","form_type":"4"}},{"id":3794204,"issuer":{"id":2083,"kind":"organization","name":"Inogen Inc","symbol":"INGN"},"owners":[{"id":37683,"kind":"person","name":"Lukatch Heath","position":1,"cik":"0001596385","reported_name":"Lukatch Heath","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-10-09T21:13:24.000Z","date":"2018-10-05","kind":"sale","acquired":false,"shares":20,"price":216.49,"value":4329.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 2, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average share price of an aggregate total of 20 shares sold in the price range of $216.03 to $216.95 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":1389,"source":{"system":"sec-edgar","filing":"0001209191-18-054560","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1294133/000120919118054560/doc4.xml","form_type":"4"}},{"id":3794203,"issuer":{"id":2083,"kind":"organization","name":"Inogen Inc","symbol":"INGN"},"owners":[{"id":37683,"kind":"person","name":"Lukatch Heath","position":1,"cik":"0001596385","reported_name":"Lukatch Heath","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-10-09T21:13:24.000Z","date":"2018-10-05","kind":"sale","acquired":false,"shares":40,"price":215.275,"value":8611.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 2, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average share price of an aggregate total of 40 shares sold in the price range of $215.00 to $215.55 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":1409,"source":{"system":"sec-edgar","filing":"0001209191-18-054560","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1294133/000120919118054560/doc4.xml","form_type":"4"}},{"id":3794202,"issuer":{"id":2083,"kind":"organization","name":"Inogen Inc","symbol":"INGN"},"owners":[{"id":37683,"kind":"person","name":"Lukatch Heath","position":1,"cik":"0001596385","reported_name":"Lukatch Heath","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-10-09T21:13:24.000Z","date":"2018-10-05","kind":"sale","acquired":false,"shares":40,"price":214.3375,"value":8573.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 2, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average share price of an aggregate total of 40 shares sold in the price range of $214.00 to $214.68 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":1449,"source":{"system":"sec-edgar","filing":"0001209191-18-054560","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1294133/000120919118054560/doc4.xml","form_type":"4"}},{"id":3794201,"issuer":{"id":2083,"kind":"organization","name":"Inogen Inc","symbol":"INGN"},"owners":[{"id":37683,"kind":"person","name":"Lukatch Heath","position":1,"cik":"0001596385","reported_name":"Lukatch Heath","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-10-09T21:13:24.000Z","date":"2018-10-05","kind":"exercise","acquired":true,"shares":500,"price":43.21,"value":21605.0,"ownership":{"direct":true},"balance_after":1489,"source":{"system":"sec-edgar","filing":"0001209191-18-054560","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1294133/000120919118054560/doc4.xml","form_type":"4"}},{"id":3821823,"issuer":{"id":2083,"kind":"organization","name":"Inogen Inc","symbol":"INGN"},"owners":[{"id":37683,"kind":"person","name":"Lukatch Heath","position":1,"cik":"0001596385","reported_name":"Lukatch Heath","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-09-07T20:08:18.000Z","date":"2018-09-06","kind":"exercise","acquired":false,"shares":500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Subject to reporting person's continuing to be a Service Provider (as defined in the 2014 Equity Incentive Plan), 1/12th of the total shares subject to the option vested monthly, beginning with the first month anniversary after the vesting commencement date, but vested fully on the date of the 2016 Annual Meeting of the Issuer's stockholders held after the vesting commencement date. The vesting commencement date for this option was October 14, 2015."}],"balance_after":7665,"derivative":{"exercise_price":43.21,"expiration_date":"2022-10-13","underlying":"Common Stock","underlying_shares":500},"source":{"system":"sec-edgar","filing":"0001209191-18-050040","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1294133/000120919118050040/doc4.xml","form_type":"4"}},{"id":3821822,"issuer":{"id":2083,"kind":"organization","name":"Inogen Inc","symbol":"INGN"},"owners":[{"id":37683,"kind":"person","name":"Lukatch Heath","position":1,"cik":"0001596385","reported_name":"Lukatch Heath","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-09-07T20:08:18.000Z","date":"2018-09-06","kind":"sale","acquired":false,"shares":195,"price":262.6974,"value":51225.993,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 2, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average share price of an aggregate total of 195 shares sold in the price range of $262.60 to $262.79 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price"}],"balance_after":989,"source":{"system":"sec-edgar","filing":"0001209191-18-050040","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1294133/000120919118050040/doc4.xml","form_type":"4"}},{"id":3821821,"issuer":{"id":2083,"kind":"organization","name":"Inogen Inc","symbol":"INGN"},"owners":[{"id":37683,"kind":"person","name":"Lukatch Heath","position":1,"cik":"0001596385","reported_name":"Lukatch Heath","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-09-07T20:08:18.000Z","date":"2018-09-06","kind":"sale","acquired":false,"shares":305,"price":260.8,"value":79544.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 2, 2018."}],"balance_after":1184,"source":{"system":"sec-edgar","filing":"0001209191-18-050040","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1294133/000120919118050040/doc4.xml","form_type":"4"}},{"id":3821820,"issuer":{"id":2083,"kind":"organization","name":"Inogen Inc","symbol":"INGN"},"owners":[{"id":37683,"kind":"person","name":"Lukatch Heath","position":1,"cik":"0001596385","reported_name":"Lukatch Heath","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-09-07T20:08:18.000Z","date":"2018-09-06","kind":"exercise","acquired":true,"shares":500,"price":43.21,"value":21605.0,"ownership":{"direct":true},"balance_after":1489,"source":{"system":"sec-edgar","filing":"0001209191-18-050040","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1294133/000120919118050040/doc4.xml","form_type":"4"}},{"id":3849582,"issuer":{"id":2083,"kind":"organization","name":"Inogen Inc","symbol":"INGN"},"owners":[{"id":37683,"kind":"person","name":"Lukatch Heath","position":1,"cik":"0001596385","reported_name":"Lukatch Heath","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-08-08T20:47:13.000Z","date":"2018-08-06","kind":"exercise","acquired":false,"shares":500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Subject to reporting person's continuing to be a Service Provider (as defined in the 2014 Equity Incentive Plan), 1/12th of the total shares subject to the option vested monthly, beginning with the first month anniversary after the vesting commencement date, but vested fully on the date of the 2016 Annual Meeting of the Issuer's stockholders held after the vesting commencement date. The vesting commencement date for this option was October 14, 2015."}],"balance_after":8165,"derivative":{"exercise_price":43.21,"expiration_date":"2022-10-13","underlying":"Common Stock","underlying_shares":500},"source":{"system":"sec-edgar","filing":"0001209191-18-045847","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1294133/000120919118045847/doc4.xml","form_type":"4"}},{"id":3849581,"issuer":{"id":2083,"kind":"organization","name":"Inogen Inc","symbol":"INGN"},"owners":[{"id":37683,"kind":"person","name":"Lukatch Heath","position":1,"cik":"0001596385","reported_name":"Lukatch Heath","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-08-08T20:47:13.000Z","date":"2018-08-06","kind":"sale","acquired":false,"shares":100,"price":212.3,"value":21230.0,"ownership":{"direct":true},"balance_after":989,"source":{"system":"sec-edgar","filing":"0001209191-18-045847","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1294133/000120919118045847/doc4.xml","form_type":"4"}},{"id":3849580,"issuer":{"id":2083,"kind":"organization","name":"Inogen Inc","symbol":"INGN"},"owners":[{"id":37683,"kind":"person","name":"Lukatch Heath","position":1,"cik":"0001596385","reported_name":"Lukatch Heath","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-08-08T20:47:13.000Z","date":"2018-08-06","kind":"sale","acquired":false,"shares":400,"price":210.5111,"value":84204.44,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 2, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average share price of an aggregate total of 400 shares sold in the price range of $210.21 to $211.03 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price"}],"balance_after":1089,"source":{"system":"sec-edgar","filing":"0001209191-18-045847","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1294133/000120919118045847/doc4.xml","form_type":"4"}},{"id":3849579,"issuer":{"id":2083,"kind":"organization","name":"Inogen Inc","symbol":"INGN"},"owners":[{"id":37683,"kind":"person","name":"Lukatch Heath","position":1,"cik":"0001596385","reported_name":"Lukatch Heath","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-08-08T20:47:13.000Z","date":"2018-08-06","kind":"exercise","acquired":true,"shares":500,"price":43.21,"value":21605.0,"ownership":{"direct":true},"balance_after":1489,"source":{"system":"sec-edgar","filing":"0001209191-18-045847","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1294133/000120919118045847/doc4.xml","form_type":"4"}},{"id":3870003,"issuer":{"id":2083,"kind":"organization","name":"Inogen Inc","symbol":"INGN"},"owners":[{"id":37683,"kind":"person","name":"Lukatch Heath","position":1,"cik":"0001596385","reported_name":"Lukatch Heath","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-07-10T20:21:11.000Z","date":"2018-07-06","kind":"exercise","acquired":false,"shares":500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Subject to reporting person's continuing to be a Service Provider (as defined in the 2014 Equity Incentive Plan), 1/12th of the total shares subject to the option vested monthly, beginning with the first month anniversary after the vesting commencement date, but vested fully on the date of the 2016 Annual Meeting of the Issuer's stockholders held after the vesting commencement date. The vesting commencement date for this option was October 14, 2015."}],"balance_after":8665,"derivative":{"exercise_price":43.21,"expiration_date":"2022-10-13","underlying":"Common Stock","underlying_shares":500},"source":{"system":"sec-edgar","filing":"0001209191-18-042152","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1294133/000120919118042152/doc4.xml","form_type":"4"}},{"id":3870002,"issuer":{"id":2083,"kind":"organization","name":"Inogen Inc","symbol":"INGN"},"owners":[{"id":37683,"kind":"person","name":"Lukatch Heath","position":1,"cik":"0001596385","reported_name":"Lukatch Heath","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-07-10T20:21:11.000Z","date":"2018-07-06","kind":"sale","acquired":false,"shares":500,"price":193.66,"value":96830.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 2, 2018."}],"balance_after":989,"source":{"system":"sec-edgar","filing":"0001209191-18-042152","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1294133/000120919118042152/doc4.xml","form_type":"4"}},{"id":3870001,"issuer":{"id":2083,"kind":"organization","name":"Inogen Inc","symbol":"INGN"},"owners":[{"id":37683,"kind":"person","name":"Lukatch Heath","position":1,"cik":"0001596385","reported_name":"Lukatch Heath","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-07-10T20:21:11.000Z","date":"2018-07-06","kind":"exercise","acquired":true,"shares":500,"price":43.21,"value":21605.0,"ownership":{"direct":true},"balance_after":1489,"source":{"system":"sec-edgar","filing":"0001209191-18-042152","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1294133/000120919118042152/doc4.xml","form_type":"4"}},{"id":3899821,"issuer":{"id":2083,"kind":"organization","name":"Inogen Inc","symbol":"INGN"},"owners":[{"id":37683,"kind":"person","name":"Lukatch Heath","position":1,"cik":"0001596385","reported_name":"Lukatch Heath","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-06-08T21:05:45.000Z","date":"2018-06-06","kind":"exercise","acquired":false,"shares":500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Subject to reporting person's continuing to be a Service Provider (as defined in the 2014 Equity Incentive Plan), 1/12th of the total shares subject to the option vested monthly, beginning with the first month anniversary after the vesting commencement date, but vested fully on the date of the 2016 Annual Meeting of the Issuer's stockholders held after the vesting commencement date. The vesting commencement date for this option was October 14, 2015."}],"balance_after":9165,"derivative":{"exercise_price":43.21,"expiration_date":"2022-10-13","underlying":"Common Stock","underlying_shares":500},"source":{"system":"sec-edgar","filing":"0001209191-18-036728","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1294133/000120919118036728/doc4.xml","form_type":"4"}},{"id":3899820,"issuer":{"id":2083,"kind":"organization","name":"Inogen Inc","symbol":"INGN"},"owners":[{"id":37683,"kind":"person","name":"Lukatch Heath","position":1,"cik":"0001596385","reported_name":"Lukatch Heath","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-06-08T21:05:45.000Z","date":"2018-06-06","kind":"sale","acquired":false,"shares":500,"price":190.58,"value":95290.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 1, 2017."}],"balance_after":989,"source":{"system":"sec-edgar","filing":"0001209191-18-036728","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1294133/000120919118036728/doc4.xml","form_type":"4"}},{"id":3899819,"issuer":{"id":2083,"kind":"organization","name":"Inogen Inc","symbol":"INGN"},"owners":[{"id":37683,"kind":"person","name":"Lukatch Heath","position":1,"cik":"0001596385","reported_name":"Lukatch Heath","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-06-08T21:05:45.000Z","date":"2018-06-06","kind":"exercise","acquired":true,"shares":500,"price":43.21,"value":21605.0,"ownership":{"direct":true},"balance_after":1489,"source":{"system":"sec-edgar","filing":"0001209191-18-036728","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1294133/000120919118036728/doc4.xml","form_type":"4"}},{"id":3934563,"issuer":{"id":2083,"kind":"organization","name":"Inogen Inc","symbol":"INGN"},"owners":[{"id":37683,"kind":"person","name":"Lukatch Heath","position":1,"cik":"0001596385","reported_name":"Lukatch Heath","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-05-14T21:46:19.000Z","date":"2018-05-10","kind":"grant","acquired":true,"shares":989,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported shares were acquired pursuant to a restricted stock unit award, which shall vest on the earlier of (i) the one-year anniversary of the date of grant, or (ii) the day prior to the date of the Annual Meeting of the Issuer's stockholders next following the date of grant, in each case, subject to the reporting person continuing to be a service provider through the applicable vesting date."}],"balance_after":989,"source":{"system":"sec-edgar","filing":"0001209191-18-029953","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1294133/000120919118029953/doc4.xml","form_type":"4"}},{"id":4019598,"issuer":{"id":2083,"kind":"organization","name":"Inogen Inc","symbol":"INGN"},"owners":[{"id":37683,"kind":"person","name":"Lukatch Heath","position":1,"cik":"0001596385","reported_name":"Lukatch Heath","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-03-02T22:45:35.000Z","date":"2018-03-01","kind":"exercise","acquired":false,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Subject to reporting person's continuing to be a Service Provider (as defined in the 2014 Equity Incentive Plan), 1/12th of the total shares subject to the option vested monthly, beginning with the first month anniversary after the vesting commencement date, but vested fully on the date of the 2016 Annual Meeting of the Issuer's stockholders held after the vesting commencement date. The vesting commencement date for this option was October 14, 2015."}],"balance_after":9665,"derivative":{"exercise_price":43.21,"expiration_date":"2022-10-13","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001209191-18-015919","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1294133/000120919118015919/doc4.xml","form_type":"4"}},{"id":4019597,"issuer":{"id":2083,"kind":"organization","name":"Inogen Inc","symbol":"INGN"},"owners":[{"id":37683,"kind":"person","name":"Lukatch Heath","position":1,"cik":"0001596385","reported_name":"Lukatch Heath","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-03-02T22:45:35.000Z","date":"2018-03-01","kind":"sale","acquired":false,"shares":300,"price":121.1617,"value":36348.51,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 1, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average share price of an aggregate total of 300 shares sold in the price range of $121.115 to $121.250 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-18-015919","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1294133/000120919118015919/doc4.xml","form_type":"4"}},{"id":4019596,"issuer":{"id":2083,"kind":"organization","name":"Inogen Inc","symbol":"INGN"},"owners":[{"id":37683,"kind":"person","name":"Lukatch Heath","position":1,"cik":"0001596385","reported_name":"Lukatch Heath","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-03-02T22:45:35.000Z","date":"2018-03-01","kind":"sale","acquired":false,"shares":1266,"price":119.2981,"value":151031.3946,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 1, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average share price of an aggregate total of 1,266 shares sold in the price range of $118.86 to $119.73 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price"}],"balance_after":300,"source":{"system":"sec-edgar","filing":"0001209191-18-015919","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1294133/000120919118015919/doc4.xml","form_type":"4"}},{"id":4019595,"issuer":{"id":2083,"kind":"organization","name":"Inogen Inc","symbol":"INGN"},"owners":[{"id":37683,"kind":"person","name":"Lukatch Heath","position":1,"cik":"0001596385","reported_name":"Lukatch Heath","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-03-02T22:45:35.000Z","date":"2018-03-01","kind":"sale","acquired":false,"shares":934,"price":118.3134,"value":110504.7156,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 1, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average share price of an aggregate total of 934 shares sold in the price range of $117.85 to $118.83 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":1566,"source":{"system":"sec-edgar","filing":"0001209191-18-015919","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1294133/000120919118015919/doc4.xml","form_type":"4"}}],"next_cursor":"2018-03-02T22:45:35.000000Z,4019595"}